We are thrilled to announce AVIDIN will participate in the partnering event be presenting at the upcoming BIO 2024 International Convention in San Diego, USA on June 3-6, 2024.

At the event, AVIDIN will showcase its preclinical cellular platform to usher in a new generation of technologies for drug discovery in the field of CNS. This technology was partly developed from grant support grants from the National Research, Development, and Innovation Office (NKFI), Hungary – 2019-1.1.1-PIACI-KFI-2019-00442; „Development, testing and production of active compounds and functional products for improving memory functions and protecting neuronal cells”.

 
At the conference, AVIDIN will share our gene expression screening solution for rapid testing of potential drugs and drug candidates influencing cellular metabolism, inflammatory pathways that are the hallmarks of metabolic diseases, including diabetes. This technology was partly developed from grant support grants from the National Research, Development, and Innovation Office (NKFI), Hungary – 2018-1.3.1-VKE-2018-00024 „Multiparametric immunophenotypic study to characterize diabetes patients”.

If you’re attending the conference, we would like to connect with you and have discussions on how we can partner in developing breakthrough technologies for the preclinical drug screening and testing. Our meetings will be scheduled in the Business Forum during the event.